Top Markets
Coin of the day
Pharmena S.a. Pharmena S.a.

Pharmena S.a.

PHR
Rangering i aksjer #32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Aksjekurs
$0.88679187
Sist synkronisert: 2026-08-17
Markedsverdi
$9.88M
Endring (1 dag)
-1.56%
Endring (1 år)
-7.71%
Land
PL
Handel Pharmena S.a. (PHR)

Kategori

P/B-forhold for Pharmena S.a. (PHR)
P/B-forhold per 2026 TTM: 0
Ifølge Pharmena S.a. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Pharmena S.a. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.4612 -
BE